New Biomarker May Improve Diagnosis of Rare Brain and Eye Cancers
The study identifies HAVCR1 as a tool for earlier detection and treatment monitoring for primary central nervous system lymphoma.
Latest Articles
Editor's Top Picks
Experts Call for End to Routine ‘Corrected’ Calcium Reporting
A new position statement warns that albumin-adjusted calcium formulas are unreliable and may lead to patient misclassification.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
ctDNA Blood Test May Help Guide Treatment Selection for Spreading Cancer
Research presented at ESTRO 2026 suggests circulating tumor DNA can identify which patients will benefit from combined radiation and drug therapy.
Equipment & Supply Spotlight
Cenevo Adds Natural Language Search to Mosaic Lab Inventory Platform
Cenevo has introduced an AI-powered natural language search feature to its Mosaic lab inventory platform, enabling scientists to locate samples using plain language queries while maintaining data traceability.
News, Know-How & Standards
Disease Detection & Understanding
Liquid Biopsy Predicts Immunotherapy Response in Breast Cancer, Study Shows
Researchers at Vanderbilt-Ingram Cancer Center report that RNA sequencing of blood samples can predict immunotherapy response in high-risk breast cancer patients.
